Giving people back their lives!

Widespread Reports of Effectiveness of HBOT in Cerebral Palsy

McGill University Pilot Study of Hyperbaric Oxygen Therapy in the Treatment of Spastic Diplegia Cerebral Palsy Duplicates and Reaffirms Widespread Reports of Effectiveness of HBOT in Cerebral Palsy

By Paul G. Harch, M.D. as printed in the first volume, issue 3 of the Hyperbaric Medicine Today journal. Visit us online at: www. hbomedtoday, com

HOTFAST: Hyperbaric Oxygen Therapy for Acute Stroke

This study will be conducted in three phases. The first phase is a feasibility study that will entail entering a minimum total of 13 patients at all of the participating centers to assess the 'feasibility of completing the protocol as well as the safety issues involved. It will be an uncontrolled trial. The data from this study will be submitted to the NIH for the second phase, which would be a fully funded, randomized, prospective,
controlled-blinded trial. Should this second phase show positive results, it may stand alone or necessitate the third phase, a much larger multicenter trial.


Dr Paul Harch M.D. - Curriculum Vitae


1976-1980 Johns Hopkins University School of Medicine

Doctor of Medicine, 1980

1972-1976 The University of California, Irvine

Bachelor of Science, Biology

Magna cum laude, Phi Beta Kappa



6/1980-12/1982 Two years general surgery training at the University of Colorado Health Sciences Center

Denver, Colorado, with six months leave for auto-ped accident

6/1986 Orientation course in hyperbaric oxygen therapy, Long Beach Medical Center, Long Beach, California

Cerebral Palsy Child from Wheelchair to Assisted Walking in Two Months

To take a hypotonic cerebral palsy child from wheelchair-bound to assisted walking in two months when all other treatments have failed is one of the most rewarding experiences in medicine.

Low Pressure Hyperbaric Oxygen Therapy, Pediatric & Adult Brain Injury, Functional Brain Imaging & Rehabilitation

Putting It All Together

The past 15 years have witnessed an explosion in the use and application of HBOT to chronic cerebral conditions. This has been accompanied by widespread negative sentiment in the medical establishment primarily due to gross ignorance of HBOT and HBOT effects on injured brain, the propagation of old misperceptions of HBOT, and the irresponsible public proclamations of uninformed doctors. The published information in medical journals has been similarly negative and lacks a basic understanding of the fundamentals of hyperbaric oxygen therapy. In addition, none of the articles in medical journals have applied the known mechanisms of HBOT to brain injury. In 1996 I sought to link the known mechanism of action of HBOT in chronic extremity wounds to chronic brain injury in animals using the protocol I first used in humans. We were successful, but needed replication of the results with a larger number of rats. That was achieved in 2001 with more powerful statistics. This model likely underpins the generic effect of HBOT in chronic brain injury and also explains the changes that are seen in SPECT brain images. In my lecture at the 3rd International Symposium in July I will tie all of this together and give the attendees a scientific framework from which they can successfully argue the application of HBOT to chronic brain injury to doctors, scientists, insurance companies, and others.

I look forward to seeing you there.

Paul G. Harch, M.D.